Prof. Maria Maddalena Cavalluzzi graduated with honors in
Pharmaceutical Chemistry and Technology in 1998 (University of Bari). In 1999
she was admitted to the PhD program in Pharmaceutical Chemistry (XIV cycle) at
the Pharmaco-Chemical Department of the University of Bari, obtaining the title
of Doctor of Research in Pharmaceutical Chemistry in 2002. In 2002 she was
awarded a two-year post-doctoral fellowship for research in the field of
Pharmaceutical Chemistry. In 2005 she was awarded a two-year Research Grant in
Pharmaceutical Chemistry, renewed for a further two years. Since February 2009
she has held the role of Assistant Professor, disciplinary sector CHIM 08, at
the Department of Pharmacy - Pharmaceutical Sciences of the University of Bari.
Her research activity is aimed at the synthesis and chemical-physical
characterization of voltage-gated Na+ channel blockers as possible anti-myotonic and antiarrhythmic agents, of hERG channel openers potentially useful
in the treatment of long QT syndrome, and the recovery of bioactive compounds
from natural matrices.
Prof. Maria Maddalena Cavalluzzi graduated with honors in
Pharmaceutical Chemistry and Technology in 1998 (University of Bari). In 1999
she was admitted to the PhD program in Pharmaceutical Chemistry (XIV cycle) at
the Pharmaco-Chemical Department of the University of Bari, obtaining the title
of Doctor of Research in Pharmaceutical Chemistry in 2002. In 2002 she was
awarded a two-year post-doctoral fellowship for research in the field of
Pharmaceutical Chemistry. In 2005 she was awarded a two-year Research Grant in
Pharmaceutical Chemistry, renewed for a further two years. Since February 2009
she has held the role of Assistant Professor, disciplinary sector CHIM 08, at
the Department of Pharmacy - Pharmaceutical Sciences of the University of Bari.
Her research activity is aimed at the synthesis and chemical-physical
characterization of voltage-gated Na+ channel blockers as possible anti-myotonic and antiarrhythmic agents, of hERG channel openers potentially useful
in the treatment of long QT syndrome, and the recovery of bioactive compounds
from natural matrices.